NCT05995197 is a NA clinical trial of action observation in Cerebral Palsy, sponsored by Medipol University.

Who is sponsoring NCT05995197?

NCT05995197 is sponsored by Medipol University.

What drugs are being tested in NCT05995197?

Interventions in NCT05995197: action observation.

What condition does NCT05995197 study?

NCT05995197 studies Cerebral Palsy, Exercise Therapy.

Is NCT05995197 still recruiting?

NCT05995197 is currently status unknown. Last updated 16 August 2023.

Last reviewed 2023-08-16 · How we verify

NCT05995197

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Action Observation Therapy on Balance in Patients With Cerebral Palsy

Status unknown NA Last updated 16 August 2023

What this trial tests

NA trial testing action observation in Cerebral Palsy in 24 participants. Status unknown.

Timeline

1 September 2023

Primary endpoint
30 September 2024

30 January 2025

Quick facts

Lead sponsor	Medipol University
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	24
Start date	1 September 2023
Primary completion	30 September 2024
Estimated completion	30 January 2025

Drugs / interventions tested

action observation

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →
Exercise Therapy — all drugs for Exercise Therapy →

Sponsor

Medipol University

Who can join

Adults 5 to 15, any sex, with Cerebral Palsy or Exercise Therapy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

type of study: clinical trial the goal of this study is to learn about action observation therapy for cerebral palsy population. The main question it aim to answer is: Is action observation therapy effective on balance in children with cerebral palsy? Twenty-four children who met the inclusion criteria in the study will be randomly divided into two groups as the training group(action observation group) and the control group.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Action observation therapy effects on motor function and balance in cerebral palsy: an fNIRS-based randomized trial.
Özipek M, Saricaoglu M, Hanoğlu L, Mutluay F. · · 2025 · PMID 41184905 · DOI 10.1186/s13063-025-09181-2

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Other Medipol University trials

Trials by the same sponsor.

NCT07277803 — Device-Based vs Manual Sensory Training in Low Back Pain · NA · not yet recruiting
NCT07214636 — Development and Investigation of the ApneaTheraPlay · NA · not yet recruiting
NCT07534475 — Venous Tourniquet vs. Arterial Tourniquet for Seizure Monitoring in ECT · NA · not yet recruiting
NCT07534488 — Sacral Erector Spinae Plane Block in Pilonidal Sinus Surgery · NA · not yet recruiting
NCT07525648 — Comparison of the Effects of Sevoflurane and Desflurane on Optic Nerve Sheath Diameter During Laparoscopic Surgery · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05995197 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Medipol University
Last refreshed: 16 August 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05995197.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing